Detke Michael J.
SEC CIK 1770786 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | Chief Medical Off | 140.0K | — | $4.15M | 5 | 2021-07-06 | 2022-03-03 |
Most active insiders at QNCX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Benatti Luca | Dir | — | $173.5K |
| 2 | Hannah Brendan | COO, CCO, CBO | — | — |
| 3 | Thye Dirk | CEO, CMO, Dir | — | — |
Detke Michael J. made no open-market trades at QNCX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-04 | 2022-03-03 | QNCX | Quince Therapeutics, Inc. | Detke Michael J. | Chief Medical Off | A - Grant | $0.00 | +140.0K | 140.0K | New | $0 | |
| D | 2021-08-12 | 2021-08-10 | QNCX | Quince Therapeutics, Inc. | Detke Michael J. | Chief Medical Off | S - Sale+OE | $100.00 | -10.0K | 0 | -100% | -$1.00M |
| D | 2021-08-12 | 2021-08-10 | QNCX | Quince Therapeutics, Inc. | Detke Michael J. | Chief Medical Off | M - OptEx | $2.23 | +10.0K | 10.0K | New | +$22.3K |
| DM | 2021-07-07 | 2021-07-06+ | QNCX | Quince Therapeutics, Inc. | Detke Michael J. | Chief Medical Off | M - OptEx | $2.23 | +30.0K | 17.4K | New | +$66.9K |
| DM | 2021-07-07 | 2021-07-06+ | QNCX | Quince Therapeutics, Inc. | Detke Michael J. | Chief Medical Off | S - Sale+OE | $54.04 | -58.3K | 523 | -99% | -$3.15M |
Purchase Sale Sale after option exercise All abbreviations